Skip to main content
. 2019 Jun 12;7(1):e000690. doi: 10.1136/bmjdrc-2019-000690

Table 3.

Ordinal logistic regression analysis for predictors of neuropathic pain among type 2 DM participants

Variable Estimate SE Wald OR (95% CI) P value
Neuropathy category 1 2.61 1.84 2.004.20 13.59 (0.37 to 504.87) 0.16
Neuropathy category 2 3.80 1.85 4.20 44.70 (1.18 to 1691.22) 0.04
Age (years) 0.02 0.02 2.33 1.02 (0.99 to 1.06) 0.13
Female gender and male gender (Ref.) 0.90 0.33 7.45 2.45 (1.29 to 4.67) <0.01
BMI (kg/m2) 0.04 0.03 1.51 1.04 (0.98 to 1.10) 0.22
Smoking and non-smoking (Ref.) 0.51 0.40 1.64 1.66 (0.76 to 3.62) 0.20
Duration of DM (years) 0.02 0.02 0.78 1.02 (0.98 to 1.07) 0.38
FBG (mmol/L) −0.06 0.04 2.81 0.94 (0.87 to 1.01) 0.09
HbA1c (%) 0.18 0.09 3.79 1.19 (1.00 to 1.43) 0.05
SBP (mm Hg) −0.01 0.01 0.92 0.99 (0.97 to 1.01) 0.34
DBP (mm Hg) <−0.01 0.02 0.01 1.00 (0.97 to 1.03) 0.91
25-hydroxyvitamin D (ng/mL) <0.01 0.01 0.03 1.00 (0.98 to 1.03) 0.86

Model fitting information: −2 Log likelihood=468.08 (intercept only) and 447.66 (final); χ2=20.42; p=0.03. Goodness of fit information: Pearson χ2=438.01; Pearson p value=0.41; deviance χ2=447.66; deviance p value=0.29. Neuropathy category 1: neuropathy score ≤12. Neuropathy category 2: neuropathy score 13–19. Neuropathy category 3: neuropathy score ≥19. P<0.05 was considered statistically significant.

BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; Ref, reference; SBP, systolic blood pressure.